drugset / Trial / NCT05292040
A Study of LY3857210 in Healthy Participants
Non-randomizedSingle-groupOpen-labelBasic science
Summary
The main purpose of this study is to evaluate the presence of study drug LY3857210 in the brain measured by positron emission tomography (PET) with the radioligand \[18F\]-LY3818850 in healthy participants. The safety and tolerability of LY3857210 will also be evaluated. The study will last up to approximately 6 weeks for each participant and may include up to four visits to the study center.
Timeline
- Start
- 2022-03-17
- Primary completion
- 2022-12-14
- Completion
- 2022-12-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY3857210 | Unknown | — | Oral |
Indications
No indication recorded.